Determination of cytomegalovirus DNA load for monitoring of cytomegalovirus disease and antiviral treatment in solid organ transplant patients, comparing limiting-dilution PCR and hybrid capture assay with cytomegalovirus isolation

Clinical Microbiology and Infection

Volumn 5, Issue 2, 1999, Pages 78-87

  Barkholt, Lisbeth ^a   Loré, Karin ^a   Tydén, Gunnar ^a   Lewensohn Fuchs, Ilona ^a   Andersson, Jan ^a   Ericzon, Bo Göran ^a   Lundgren, Göran ^a   Ehrnst, Anneka ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antivirals; CMV; Disease; PCR; Quantification; Transplantation

Indexed keywords

ANTIVIRUS AGENT; DNA HYBRID; EDETIC ACID; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTION; DILUTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KINETICS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; VIRUS ISOLATION; VIRUS LOAD;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES;

EID: 0033025401     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00107.x     Document Type: Article

References (47)

1. Rand KH, Merigan TC. Cytomegalovirus, a not so innocent by-stander. JAMA 1978: 240: 2470.
2. Ho M. Immunosuppressive effect of cytomegalovirus infection. In Ho M, ed. Cytomegalovirus. Biology and infection. New York: Plenum Publishing Corporation, 1992: 267-70.
3. Friese C. Roberts J. Comparison ot three CMV prophylaxis protocols in 107 liver transplant recipients. Transplant Proc 1991; 23: 1498-500.
4. Martin M, Manez R, Linden P, et al. A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1994; 58: 779-85.
5. O'Grady JG, Alexander GJ, Sutherland S, et al. Cytomegalovirus intection and donor/recipient HLA antigens: interdependent cofactors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988; ii: 302.
6. Arnold JC, Portman BC, O'Grady JG, et al. Cytomegalovirus intection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 1992; 16: 285-92.
7. Cassol SA, Poon M-C, Pal R, et al. Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV intection in marrow transplant recipients. J Clin Invest 1989; 83: 1109-15.
8. Einsele H, Ehninger G, Steidle M, et al. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 1991; 338: 1170-2.
9. Gerna G, Zipeto D, Parea M. et al. Monitoring of human cytomegalovirus and ganciclovir treatment in heart transplant recipients by determination of viraemia, antigenemia and DNAemia. J Infect Dis 1991; 164: 488-98.
10. Schmid CA, Oettle H, Peng R, et al. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation 1995; 59: 1133-8.
11. Sandin RL, Rodriquez EZ, Rosenberg D, et al. Comparison of sensitivity for human cytomegalovirus of the polymerase chain reaction, traditional tube culture and shell vial assay by sequential dilution of infected cell lines. J Virol Methods 1991; 32: 181-91.
12. Drouet E, Michelson S, Denoyel G, Colimon R. Polymerase chain reaction detection of HCMV in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion. J Virol Methods 1993; 45: 259-76.
13. Drouet E, Colimon R, Michelson S. et al. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol 1995; 33: 389-94.
14. Gerdes JC, Specs EK, Fitting K, et al. Prospective study utilizing a quantitative polymerase chain reaction for detection of cytomegalovirus DNA in the blood of renal transplant patients. Transplant Proc 1993; 25: 1411-13.
15. Schafer P, Braun RW, Mohring K. et al. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J Gen Virol 1993; 74: 2699-707.
16. Kuhn JE, Wendland T, Schafer P. et al. Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes. J Med Virol 1994; 44: 398-405.
17. Brytting M, Mousavi-Jazi M, Boström L, et al. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Transplantation 1995; 60: 901-5.
18. Boivin G, Olson CA, Quirk MR, St Cyr SM, Jordan MC. Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PGR and a rapid fluorescence-based detection system. J Virol Methods 1995; 51: 332-42.
19. Fox JC, Kidd IM, Griffiths PD, Sweny P, Emery VC. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol 1995; 76: 309-19.
20. Mutimer D, Matyi-Toth A, Elias E, et al. Quantitation of cytomegalovirus in the blood of liver transplant recipients. Liver Transplant Surg 1995; 1: 395-400.
21. Ljungman P, Loré K, Aschan J, et al. Use of a semiquantitative PCR for cytomegalovirus DNA as a basis for preemptive anti-viral therapy in allogenic bone marrow transplant patients. Bone Marrow Transplant 1996; 17: 583-7.
22. Grundy JE, Ehrnst A, Einsele H, et al. A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood. J Clin Microbiol 1996; 34: 1166-70.
23. Ehrnst A, Barkholt L, Lewensohn-Fuchs I, et al. CMV PCR monitoring in leukocytes of transplant patients. Clin Diagn Virol 1995; 3: 139-53.
24. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 307-15.
25. Barkholt L, Ehrnst A, Veress D. Clinical use of immunohistopathological methods for the diagnosis of cytomegalovirus hepatitis in human liver allograft biopsies. Scand J Gastroenterol 1994; 29: 553-00.
26. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In Michelson S. Plotkin SA, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Elsevier Science Publishers BV: Amsterdam, 1993: 233-7.
27. Ehrnst A, Barkholt L, Brattstöm C. et al. Detection of CMV-matrix pp65 antigen in leukocytes by immunofluorescence as a marker of CMV disease. J Med Virol 1993; 39: 118-24.
28. Heurlin N, Brattström C, Lonnqvist B, Westman L, Lidman C, Andersson J. Aetiology of pulmonary disease in immunocompromised patients. Eur Respir J 1991; 4: 10-18.
29. Barkholt L, Johansson B, Veress B, Andersson JP, Ehrnst A. Polymerase chain reaction for the early diagnosis of cytomegalovirus hepatitis in liver transplant patients. Clin Diagn Virol 1995; 4: 121-34.
30. Böyum A. Isolation ot leukocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest 1968; 21 (suppl 97): 9-29.
31. Böyum A. Separation of leukocytes: improvement in cell purity by fine adjustments of gradient, medium density and osmolality. Scand J Immunol 1991; 34: 697-712.
32. Porter-Jordan K, Rosenberg EI, Keiser JF, et al. Nested polymerase chain reaction assay for the detection of cytomegalovirus overcomes false positives caused by contamination with fragmented DNA. J Med Virol 1990; 30: 85-91.
33. Imbert-Marcille B-M, Cantarovich D, Boedec S, Vernoux L, Soulillou J-P, Billaudel S. Evaluation of a new quantification method for cytomegalovirus DNA in leukocytes: clinical value in renal transplant recipients. Scand J Infect Dis 1995; 99 (suppl): 15-16.
34. Jiwa NM, van Gemert GQ, Raap AL, et al. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation 1989; 48: 72-6.
35. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after bone marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 1990; 162: 373-80.
36. Ehrnst A, Einsele H. Towards standardizations of cytomegalovirus DNA PCR assays. Scand J Infect Dis Suppl 1995; 99: 16-18.
37. Rawal BK, Booth JC, Fernando S, Butcher PD, Powles RL. Quantification of cytomegalovirus DNA in blood specimens from bone marrow transplant recipients by polymerase chain reaction. J Virol Methods 1994; 47: 189-202.
38. Nelson PN, Rawal BK, Boriskin YS, et al. A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients. J Virol Methods 1996; 56: 139-48.
39. The TH, van der Ploeg P, van der Bij W, et al. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193-8.
40. van der Bij W, Schirm J, Torensma R, et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microhiol 1989; 26: 2531-5.
41. Danker WM, McCutchan JA, Richman DD, et al. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis 1990; 161: 31-6.
42. Imbert-Marcille B-M, Cantarovich D, Ferre-Aubineau V, Richet B, Soulillou J-P, Billaudel S. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients. Transplantation 1997; 63: 1476-81.
43. Macartney M, Gane EJ, Portmann B, Williams R. Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods Transplantation 1997; 63: 1803-7.
44. Wolff C, Skourtopoulos M, Hörnschemeyer D. et al. Significance of human cytomegalovirus DNA detection in immunocompromised heart transplant patients. Transplantation 1996; 61: 750-7.
45. Poirier-Toulmonde AS, Imbert-Marcillel BM. Ferre-Aubineau V, et al. Successful quantification of cytomegalovirus DNA by competitive PCR and detection with capillary electrophoresis. Mol Cell Probes 1997; 11: 11-23.
46. Toyota M, Carlos JB, Galera OA. et al. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 1997; 63: 957-63.
47. Baldanti F, Sarasini A, Silini E, et al. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for gauciclovir-and foscarnet-specific resistance, respectively. Scand J Infect Dis Suppl 1995; 99: 103-5.